Integration of the Dunkirk site (France)
Together with a portfolio of generic APIs, Minakem acquired the Dunkirk site from AstraZeneca as a state-of-the-art manufacturing asset for commercial APIs.
2009
|Published on: Oct 13, 2016|Categories: |
Recent Posts
- Minasolve Welcomes Marielle Le Maire as Managing Director
- Minafin Group appoints Olivier Ubrich as CEO of Health Chemistry Division
- Minafin has strengthened its Healthcare Chemicals division with the acquisition of Delmar in Montreal, Canada
- Frédéric Gauchet elected President of France Chimie
- Origin Materials and Minafin Group Launch Manufacturing Initiative for Origin’s First Commercial Plant
Archives
- October 2024
- September 2024
- July 2023
- April 2023
- October 2022
- September 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- April 2021
- February 2021
- October 2020
- June 2020
- May 2020
- April 2020
- March 2020
- January 2020
- December 2019
- November 2019
- March 2019
- February 2019
- October 2018
- June 2018
- May 2018
- March 2018
- February 2018
- January 2018
- December 2017
- October 2017
- June 2017
- December 2016
- April 2016
- September 2015
- June 2015
- April 2014
- March 2014
- September 2013
- February 2013
- December 2012
- November 2011
- June 2010
- April 2010